HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression of P2X₇ receptors in EPCs and their potential role in the targeting of EPCs to brain gliomas.

Abstract
In order to use endothelial progenitor cells (EPCs) as a therapeutic and imaging probe to overcome antiangiogenic resistance for gliomas, how to enhance proliferation and targeting ability of transplanted EPCs is a high priority. Here, we confirmed, for the first time, the expression of P2X7 receptors in rat spleen-derived EPCs. Activation of P2X7 receptors in EPCs by BzATP promoted cells proliferation and migration, rather than apoptosis. In vivo, the homing of transplanted EPCs after long-term suppression of P2X7 receptors by persistent BBG stimulation was evaluated by MRI, immunohistochemistry and flow cytometry. Compared to the group without BBG treatment, less transplanted EPCs homed to gliomas in the group with BBG treatment, especially integrated into the vessels containing tumor-derived endothelial cells in gliomas. Moreover, western blot showed that CXCL1 expression was downregulated in gliomas with BBG treatment, which meant P2X7 receptors suppression inhibited the homing of EPCs to gliomas through down-regulation of CXCLl expression. Further, effects of P2X7 receptors on C6 glioma cells or gliomas were evaluated at the same dose of BzATP or BBG used in EPCs experiments in vitro and in vivo. MTT assay and MRI revealed that P2X7 receptors exerted no significant promoting effect on C6 glioma cells proliferation, gliomas growth and angiogenesis. Taken together, our findings imply the possibility of promoting proliferation and targeting ability of transplanted EPCs to brain gliomas in vivo through P2X7 receptors, which may provide new perspectives on application of EPCs as a therapeutic and imaging probe to overcome antiangiogenic resistance for gliomas.
AuthorsJingqin Fang, Xiao Chen, Shunan Wang, Tian Xie, Xuesong Du, Heng Liu, Sumei Wang, Xue Li, Jinhua Chen, Bo Zhang, Huaping Liang, Yizeng Yang, Weiguo Zhang
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 16 Issue 4 Pg. 498-510 ( 2015) ISSN: 1555-8576 [Electronic] United States
PMID25839324 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CXCL1 protein, human
  • Chemokine CXCL1
  • P2RX7 protein, human
  • Receptors, Purinergic P2X7
Topics
  • Animals
  • Brain Neoplasms (genetics)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cell Proliferation (genetics)
  • Chemokine CXCL1 (genetics)
  • Down-Regulation (genetics)
  • Endothelial Progenitor Cells (metabolism)
  • Glioma (genetics)
  • Humans
  • Male
  • Neovascularization, Pathologic (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2X7 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: